BioNTech SE
BNTX
$96.46
-$0.27-0.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.46% | 29.76% | -786.05% | -171.78% | -117.67% |
| Total Depreciation and Amortization | 85.40% | 45.75% | 57.15% | 61.67% | 60.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.90% | -213.26% | -15.58% | 50.53% | 77.71% |
| Change in Net Operating Assets | -91.70% | -135.57% | -89.97% | -78.44% | -48.69% |
| Cash from Operations | -114.59% | -157.75% | -104.28% | -96.40% | -71.95% |
| Capital Expenditure | 40.68% | 24.21% | -4.31% | -14.56% | -2.83% |
| Sale of Property, Plant, and Equipment | 859.51% | 907.76% | -- | -- | 166.68% |
| Cash Acquisitions | -- | 77.47% | 77.47% | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 119.61% | 132.28% | 122.38% | 71.51% | -33.84% |
| Cash from Investing | 113.82% | 124.69% | 116.70% | 69.82% | -21.51% |
| Total Debt Issued | -- | -- | -- | -- | -33.33% |
| Total Debt Repaid | 9.82% | 19.27% | -33.42% | -13.61% | -36.46% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 99.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.70% | 88.05% | 89.67% | 94.12% | 93.78% |
| Foreign Exchange rate Adjustments | 88.51% | 106.83% | -137.46% | 215.44% | -725.33% |
| Miscellaneous Cash Flow Adjustments | -109.51% | -84.54% | -44.69% | -98.06% | 38,089.00% |
| Net Change in Cash | 111.43% | 96.61% | 137.21% | 11.32% | -5,620.30% |